Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk reduction, cardiologists and primary care providers should also consider using these agents for patients with type 2 diabetes and heart https://www.healio.com/endocrinology/diabetes/news/online/%7Ba85e9fe7-cd5b-4e4e-a13f-9c0ac4c1b6e3%7D/cardiologists-should-consider-prescribing-glp1-agents-for-cvd-prevention-in-type-2-diabetes